drugset / Trial / NCT03621553

Vitamin D Homeostasis in Sarcoidosis

NCT03621553

Phase 4 Recruiting 90 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.

Timeline

Start
2010-07-01
Primary completion
2026-02
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ergocalciferol Small molecule 50000 iu Oral
Background Calcium Citrate with Vitamin D2 Unknown 200 mg Oral
Background Calcium Citrate with Vitamin D2 Unknown 250 iu Oral